Despite concerns about the Trump government's shake-up of the agency, the US Food and Drug Administration remains the first ...

Babies born with heart defects may be at increased risk for cancer within the first 10 years of life, according to new research that suggests mothers may also be at ...

The actor stresses the importance of advocating for yourself after both her parents were diagnosed with cancer and she had ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

Two-time major champion and fan favorite John Daly is among the latest golfers to commit to the Galleri Classic presented by ...

While the heavily advertised at-home stool tests certainly can be a useful, extra screening tool for detecting colon cancer, ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Multi-cancer early detection screening requires a simple blood draw, and it checks for some of the deadliest cancers.

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

CRE Debt and Equity specialists, MaxCap Group MaxCap Group, a strategic investment partner of Apollo, is a leading Australian Commercial Real Estate Debt investment manager. With $7 billion Funds ...

GRAIL, Inc. (NASDAQ:GRAL) is a biotechnology company focusing on developing the next generation of cancer diagnostic tools that will help doctors identify dangers early on and maybe prevent lethal ...